Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy, tolerability, and safety of oral sulopenem-etzadroxil/probenecid versus oral ciprofloxacin for treatment of uncomplicated urinary tract infection (uUTI) in adult women
Epistemonikos ID: b460f3edb1101b54291922f380e3a7112cbe548e
First added on: May 21, 2024